Header cover image

U.S. Clinical Research and Equipment Industry Analysis

UpdatedSep 26, 2023
DataAggregated Company Financials
Companies77
  • 7D-2.0%
  • 3M-1.1%
  • 1Y-1.0%
  • YTD-6.9%

Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.0%, driven by a pullback from Illumina of 7.7%. In contrast, Alpha Teknova has gained 29%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 Sep 2023US$674.7bUS$154.6bUS$11.2b33.7x60.2x4.4x
Thu, 24 Aug 2023US$713.3bUS$154.6bUS$11.2b32.8x63.6x4.6x
Sat, 22 Jul 2023US$741.4bUS$155.5bUS$12.7b29.4x58.4x4.8x
Mon, 19 Jun 2023US$704.3bUS$152.4bUS$12.5b29.3x56.3x4.6x
Wed, 17 May 2023US$672.0bUS$152.4bUS$12.6b28.2x53.2x4.4x
Fri, 14 Apr 2023US$744.3bUS$154.6bUS$10.8b30.7x68.9x4.8x
Sun, 12 Mar 2023US$693.6bUS$154.5bUS$10.9b29.6x63.9x4.5x
Tue, 07 Feb 2023US$758.4bUS$155.7bUS$9.1b31.5x83.3x4.9x
Thu, 05 Jan 2023US$734.2bUS$155.2bUS$8.8b28.9x83.7x4.7x
Sat, 03 Dec 2022US$781.0bUS$155.1bUS$8.8b28.9x89x5x
Mon, 31 Oct 2022US$720.5bUS$154.5bUS$13.0b27x55.6x4.7x
Wed, 28 Sep 2022US$699.1bUS$152.2bUS$17.3b23.8x40.4x4.6x
Fri, 26 Aug 2022US$803.5bUS$152.2bUS$17.3b31.1x46.4x5.3x
Sun, 24 Jul 2022US$787.5bUS$148.7bUS$20.2b32.1x39x5.3x
Tue, 21 Jun 2022US$674.6bUS$148.1bUS$20.1b27.5x33.6x4.6x
Thu, 19 May 2022US$731.6bUS$148.0bUS$20.0b31.5x36.5x4.9x
Sat, 16 Apr 2022US$839.5bUS$146.5bUS$25.3b36.4x33.1x5.7x
Mon, 14 Mar 2022US$792.0bUS$145.3bUS$25.2b33.5x31.5x5.5x
Wed, 09 Feb 2022US$859.1bUS$139.8bUS$26.9b38.8x31.9x6.1x
Fri, 07 Jan 2022US$916.3bUS$138.0bUS$27.3b42.6x33.5x6.6x
Sun, 05 Dec 2021US$942.0bUS$138.0bUS$27.3b43.1x34.5x6.8x
Tue, 02 Nov 2021US$766.1bUS$107.8bUS$21.5b49.2x35.6x7.1x
Thu, 30 Sep 2021US$720.1bUS$105.9bUS$18.6b48.7x38.6x6.8x
Sat, 28 Aug 2021US$727.9bUS$105.8bUS$18.7b52x39x6.9x
Sun, 04 Jul 2021US$656.3bUS$101.0bUS$17.6b39.3x37.2x6.5x
Wed, 07 Apr 2021US$569.5bUS$92.3bUS$15.4b38.8x37x6.2x
Sat, 09 Jan 2021US$553.9bUS$89.0bUS$14.2b39x39x6.2x
Fri, 02 Oct 2020US$450.0bUS$79.8bUS$11.8b38.6x38.2x5.6x
Price to Earnings Ratio

38.2x


Total Market Cap: US$450.0bTotal Earnings: US$11.8bTotal Revenue: US$79.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Clinical Research and Equipment Industry Price to Earnings3Y Average 47.2x202120222023
Current Industry PE
  • Investors are optimistic on the American Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 60.2x which is higher than its 3-year average PE of 47.2x.
  • The 3-year average PS ratio of 5.6x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 25% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does U.S. Clinical Research and Equipment compare with similar industries?

US Market-2.69%
Healthcare-1.09%
Life Sciences-2.02%
Clinical Research and Equipment-2.02%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TKNO Alpha TeknovaUS$2.3129.1%
+US$43.4m
-37.4%PS2.4x
OLK Olink HoldingUS$15.041.9%
+US$34.8m
18.4%PS12.8x
BLFS BioLife SolutionsUS$13.304.5%
+US$24.8m
-38.4%PS3.6x
SHC Sotera HealthUS$15.390.4%
+US$17.0m
113.5%PS4.5x
SLGC SomaLogicUS$2.342.6%
+US$11.3m
-19.3%PS4.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IQV

US$202.39

IQVIA Holdings

7D

-3.3%

1Y

8.8%

TMO

US$505.66

Thermo Fisher Scientific

7D

-0.4%

1Y

-1.7%

ILMN

US$131.41

Illumina

7D

-7.7%

1Y

-28.6%

TKNO

US$2.31

Alpha Teknova

7D

29.1%

1Y

-37.4%

DHR

US$252.04

Danaher

7D

-0.7%

1Y

-4.0%

AKYA

US$4.43

Akoya Biosciences

7D

4.5%

1Y

-58.3%

OLK

US$15.04

Olink Holding

7D

1.9%

1Y

18.4%

SNCE

US$0.40

Science 37 Holdings

7D

24.2%

1Y

-75.5%

SLGC

US$2.34

SomaLogic

7D

2.6%

1Y

-19.3%